FGF21 and GDF15 are used as biomarkers for the diagnosis and severity assessment of mitochondrial diseases including mitochondrial myopathy, [46, 47], but they were also shown to be elevated in patients with different inherited metabolic diseases that are not restricted to mitochondrial disorders [48]. This evidence concerns the gene GDF15 and mitochondrial disease.